Evidence map›Paper›PMID 27300328›Full record

ArticlePLoS pathogens2016

Atomic Structure and Biochemical Characterization of an RNA Endonuclease in the N Terminus of Andes Virus L Protein.

Yaiza Fernández-García, Juan Reguera, Carola Busch, Gregor Witte, Oliberto Sánchez-Ramos, Christian Betzel, Stephen Cusack, Stephan Günther, Sophia Reindl

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Pharmacophores of Influenza Virus PA Endonuclease Inhibitors.Advances in experimental medicine and biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Biochemical characterization of the Lassa virus L protein.The Journal of biological chemistry · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Yaiza Fernández-GarcíaDepartment of Virology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
Juan RegueraEuropean Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.
Carola BuschDepartment of Virology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
Gregor WitteGene Center, Department of Biochemistry, Ludwig-Maximilians-Universität, Munich, Germany.
Oliberto Sánchez-RamosDepartment of Pharmacology, University of Concepción, Concepción, Chile.
Christian BetzelLaboratory for Structural Biology of Infection and Inflammation, University of Hamburg, Hamburg, Germany.
Stephen CusackEuropean Molecular Biology Laboratory, Grenoble Outstation, Grenoble, France.
Stephan GüntherDepartment of Virology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
Sophia ReindlDepartment of Virology, Bernhard-Nocht-Institute for Tropical Medicine, Hamburg, Germany.
Bernhard Nocht Institute for Tropical Medicine · DEEuropean Molecular Biology Laboratory · FRUniversity of Concepción · CLLudwig-Maximilians-Universität München · DEUniversität Hamburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Andes virus (ANDV) is a human-pathogenic hantavirus. Hantaviruses presumably initiate their mRNA synthesis by using cap structures derived from host cell mRNAs, a mechanism called cap-snatching. A signature for a cap-snatching endonuclease is present in the N terminus of hantavirus L proteins. In this study, we aimed to solve the atomic structure of the ANDV endonuclease and characterize its biochemical features. However, the wild-type protein was refractory to expression in Escherichia coli, presumably due to toxic enzyme activity. To circumvent this problem, we introduced attenuating mutations in the domain that were previously shown to enhance L protein expression in mammalian cells. Using this approach, 13 mutant proteins encompassing ANDV L protein residues 1-200 were successfully expressed and purified. Protein stability and nuclease activity of the mutants was analyzed and the crystal structure of one mutant was solved to a resolution of 2.4 Å. Shape in solution was determined by small angle X-ray scattering. The ANDV endonuclease showed structural similarities to related enzymes of orthobunya-, arena-, and orthomyxoviruses, but also differences such as elongated shape and positively charged patches surrounding the active site. The enzyme was dependent on manganese, which is bound to the active site, most efficiently cleaved single-stranded RNA substrates, did not cleave DNA, and could be inhibited by known endonuclease inhibitors. The atomic structure in conjunction with stability and activity data for the 13 mutant enzymes facilitated inference of structure-function relationships in the protein. In conclusion, we solved the structure of a hantavirus cap-snatching endonuclease, elucidated its catalytic properties, and present a highly active mutant form, which allows for inhibitor screening.

Indexed as

Amino Acid SequenceCrystallography, X-RayEndonucleasesOrthohantavirusProtein ConformationProtein StabilityRNA-Dependent RNA PolymeraseStructure-Activity RelationshipViral ProteinsEndonucleasesL protein, hantavirusRNA-Dependent RNA PolymeraseViral Proteins

Identifiers

PMID27300328
PMCPMC4907427
OpenAlexW2437090616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.